Experimental model and novel therapeutic targets for non-alcoholic fatty liver disease development

被引：2
|
作者：
Jin, Yujin
Heo, Kyung-Sun [1 ]
机构：
[1] Chungnam Natl Univ, Coll Pharm, Daejeon 34134, South Korea
来源：
KOREAN JOURNAL OF PHYSIOLOGY & PHARMACOLOGY | 2023年 / 27卷 / 04期
基金：
新加坡国家研究基金会;
关键词：
Drug targeting; Hepatitis; Metabolic syndrome; Non-alcoholic fatty liver disease; LIPID-ACCUMULATION; MOUSE MODEL; ER STRESS; INFLAMMATION; APOPTOSIS; ACTIVATION; FIBROSIS; PATHWAY; CANCER; STEATOHEPATITIS;
D O I：
10.4196/kjpp.2023.27.4.299
中图分类号：
R9 [药学];
学科分类号：
1007 ;
摘要：
Non-alcoholic fatty liver disease (NAFLD) is a complex disorder characterized by the accumulation of fat in the liver in the absence of excessive alcohol consumption. It is one of the most common liver diseases worldwide, affecting approximately 25% of the global population. It is closely associated with obesity, type 2 diabetes, and metabolic syndrome. Moreover, NAFLD can progress to non-alcoholic steatohepatitis, which can cause liver cirrhosis, liver failure, and hepatocellular carcinoma. Currently, there are no approved drugs for the treatment of NAFLD. Therefore, the development of effective drugs is essential for NAFLD treatment. In this article, we discuss the experimental models and novel therapeutic targets for NAFLD. Additionally, we propose new strategies for the development of drugs for NAFLD.
引用
收藏
页码：299 / 310
页数：12
相关论文
共 50 条
  • [41] Identification of novel targets in adipose tissue involved in non-alcoholic fatty liver disease progression
    Lopez-Yus, Marta
    Lorente-Cebrian, Silvia
    Horndler, Carlos
    Sobrino-Prados, Almudena
    Casamayor, Carmen
    Sanz Paris, Alejandro
    Bernal Monterde, Vanesa
    Arbones Mainar, Jose M.
    JOURNAL OF HEPATOLOGY, 2022, 77 : S676 - S676
  • [42] Identification of novel targets in adipose tissue involved in non-alcoholic fatty liver disease progression
    Lopez-Yus, Marta
    Lorente-Cebrian, Silvia
    Del Moral-Bergos, Raquel
    Horndler, Carlos
    Pilar Garcia-Sobreviela, Maria
    Casamayor, Carmen
    Sanz-Paris, Alejandro
    Bernal-Monterde, Vanesa
    Arbones-Mainar, Jose M.
    FASEB JOURNAL, 2022, 36 (08):
  • [43] Parental non-alcoholic fatty liver disease increases risk of non-alcoholic fatty liver disease in offspring
    Long, Michelle T.
    Gurary, Ellen B.
    Massaro, Joseph M.
    Ma, Jiantao
    Hoffmann, Udo
    Chung, Raymond T.
    Benjamin, Emelia J.
    Loomba, Rohit
    LIVER INTERNATIONAL, 2019, 39 (04) : 740 - 747
  • [44] Development of machine learning model to detect fibrotic non-alcoholic steatohepatitis in patients with non-alcoholic fatty liver disease
    Aggarwal, Manik
    Rozenbaum, Daniel
    Bansal, Agam
    Garg, Rajat
    Bansal, Parikshit
    McCullough, Arthur
    DIGESTIVE AND LIVER DISEASE, 2021, 53 (12) : 1669 - 1672
  • [45] Adipokines in Non-Alcoholic Fatty Liver Disease: Are We on the Road toward New Biomarkers and Therapeutic Targets?
    Francisco, Vera
    Jesus Sanz, Maria
    Real, Jose T.
    Marques, Patrice
    Capuozzo, Maurizio
    Ait Eldjoudi, Djedjiga
    Gualillo, Oreste
    BIOLOGY-BASEL, 2022, 11 (08):
  • [46] Exploration of the Key Genes Involved in Non-alcoholic Fatty Liver Disease and Possible MicroRNA Therapeutic Targets
    Mahmoudi, Ali
    Jalili, Amin
    Butler, Alexandra E.
    Aghaee-Bakhtiari, Seyed H.
    Jamialahmadi, Tannaz
    Sahebkar, Amirhossein
    JOURNAL OF CLINICAL AND EXPERIMENTAL HEPATOLOGY, 2024, 14 (04)
  • [47] Identification of new therapeutic targets for hepatic regenerative medicine in Non-Alcoholic Fatty Liver Disease (NAFLD)
    Hora, Shainan
    Gao, Rong
    Iakovleva, Viktoriia
    Bee, Agnes
    Ong, Leng
    Wuestefeld, Torsten
    JOURNAL OF HEPATOLOGY, 2022, 77 : S730 - S731
  • [48] Decreasing the burden of non-alcoholic fatty liver disease: From therapeutic targets to drug discovery opportunities
    Amorim, Ricardo
    Soares, Pedro
    Chavarria, Daniel
    Benfeito, Sofia
    Cagide, Fernando
    Oliveira, Paulo J.
    Borges, Fernanda
    EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY, 2024, 277
  • [49] The NLRP3 Inflammasome in Non-Alcoholic Fatty Liver Disease and Steatohepatitis: Therapeutic Targets and Treatment
    Yu, Lili
    Hong, Wei
    Lu, Shen
    Li, Yanrong
    Guan, Yaya
    Weng, Xiaogang
    Feng, Zhiwei
    FRONTIERS IN PHARMACOLOGY, 2022, 13
  • [50] The development of a non-invasive model to predict the presence of non-alcoholic steatohepatitis in patients with non-alcoholic fatty liver disease
    Goh, George B. B.
    Issa, Danny
    Lopez, Rocio
    Dasarathy, Srinivasan
    Dasarathy, Jaividhya
    Sargent, Ruth
    Hawkins, Carol
    Pai, Rish K.
    Yerian, Lisa
    Khiyami, Amer
    Pagadala, Mangesh R.
    Sourianarayanane, Achuthan
    Alkhouri, Naim
    McCullough, Arthur J.
    JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY, 2016, 31 (05) : 995 - 1000
12345